• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
WANG Honghong,HE Jing,YU Qiao'ai,JIANG Yongjiang,HUANG Yuling.Study of fluconazole prophylaxis for invasive candidiasis in preterm infant[J].Journal Of Pharmaceutical Research,2022,41(5):319-321,345[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 2257times   Download 2107次 QR Code for this article
Scan with your phone!
氟康唑预防早产儿侵袭性念珠菌病的研究进展
王宏虹1,2,3,何静1,于桥爱4,蒋永江5,黄玉玲1
Font:Larger+|Default|Smaller-
(1.柳州市妇幼保健院药学部,广西科技大学附属妇产医院、儿童医院药学部,广西 柳州 545001;2.广西医科大学公共卫生学院,广西 南宁 530021;3.广西基因组与个体化医学重点实验室,广西基因组与个体化医学协同创新中心,广西高等学校重点实验室,广西 南宁 530021;4.柳州市妇幼保健院医学检验科,广西 柳州 545001;5.柳州市妇幼保健院新生儿科,广西 柳州 545001)
摘要:
随着我国计划生育政策的变化,新生儿早产率持续上升,因早产儿免疫功能低下,侵袭性念珠菌病(IC)是导致早产儿致残、致死的重要原因。近年来临床尝试小剂量使用氟康唑预防早产儿IC,但在给药方案及安全性方面存在争议。本文就念珠菌的耐药现状,氟康唑的抗菌活性、PK/PD特点及预防IC的有效性、安全性研究进行综述,为临床用药提供参考。
关键词:  氟康唑  念珠菌  早产儿  预防用药
DOI:10.13506/j.cnki.jpr.2022.05.009
基金项目:广西自然科学基金青年基金项目(No.2018GXNSFBA281156);柳州市科技计划项目(No.2019BJ10603);柳州市科技计划项目(No.2018AF10501)
Publication Date:May 25, 2022
Study of fluconazole prophylaxis for invasive candidiasis in preterm infant
WANG Honghong1,2,3,HE Jing1,YU Qiao'ai4,JIANG Yongjiang5,HUANG Yuling1
(1.Department of Pharmacy, Liuzhou Maternity and Child Healthcare Hospital; Affiliated Maternity Hospital and Affiliated Children’s Hospital of Guangxi University of Science and Technology, Guangxi Liuzhou 545001, China; 2. School of Public Health Guangxi Medical University, Guangxi Nanning 530021, China;; 3.Guangxi key Laboratory for Genomic and Personalized Medicine; Guangxi Collaborative Innovation Center for Genomic and Personalized Medicine; Guangxi Key Laboratory of Colleges and Universities, Guangxi Nanning 530021, China;4. Medical laboratory, Liuzhou Maternity and Child Healthcare Hospital, Guangxi Liuzhou 545001, China;5. Department of Neonatology, Liuzhou Maternity and Child Healthcare Hospital, Guangxi Liuzhou 545001, China)
Abstract:
With the change of China's family planning policy, the birth rate of preterm infants continues to rise. Invasive candidiasis (IC) is an important cause of disability and death of preterm infants due to poor immune function.In recent years, low-dose fluconazole has been tried to prevent IC in preterm infants, but the safety and efficacy remain controversial. In this paper, the status of resistance of Candida, the antibacterial activity, PK/PD characteristics of fluconazole and the effectiveness and safety of IC prevention were reviewed, providing reference for clinical application.
Key words:  Preterm infant  Candidiasis  Prophylaxis
Today's Visits:527    Total Visits:2383269
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.